Poly Medicure to hold investor meets on Aug 27, 31
- Poly Medicure scheduled analyst meets for Aug 27 and Aug 31, 2026
- Bandhan AMC meeting to be held virtually at 3:40 pm
- Sparx Capital session at registered office at 4:00 pm
- Meetings comply with SEBI LODR Regulation 30 requirements
- No unpublished price-sensitive info to be shared
*this image is generated using AI for illustrative purposes only.
Poly Medicure Limited has scheduled one-on-one meetings with analysts and investors for August 27 and August 31, 2026. The engagements are part of the company’s ongoing disclosure obligations under SEBI regulations.
The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. These interactions aim to provide market participants with updates on the business, subject to regulatory guidelines.
Meeting Schedule
The management team will host two separate sessions during the latter half of August. One meeting is virtual, while the other will be held at the registered office in New Delhi.
| Participant | Date | Time | Venue | Format |
|---|---|---|---|---|
| Bandhan AMC | August 27, 2026 | 3:40 pm | Virtual | One-on-one |
| Sparx Capital | August 31, 2026 | 4:00 pm | Registered Office | One-on-one |
Regulatory Compliance
The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of price-sensitive information to stock exchanges.
Avinash Chandra, Company Secretary, signed the communication. He confirmed that no unpublished price-sensitive information will be shared during these meetings. The schedule remains subject to change due to exigencies on the part of the analysts, investors, or the company.
Investors can access further details on the company’s website.
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.84% | -5.15% | -0.09% | +36.92% | -12.58% | +89.59% |
How might the insights shared during these one-on-one sessions influence Poly Medicure's valuation multiples in the near term?
What specific operational or strategic updates are analysts likely to probe regarding the company's export markets and regulatory approvals?
Could the timing of these meetings in late August 2026 signal an upcoming earnings announcement or material corporate action?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
